• Electrofisiologia

• Arritmias

1: Roca-Luque I, Zaraket F, Garre P, Sanchez-Somonte P, Quinto L, Borras R, Guasch E, Arbelo E, Tolosana JM, Brugada J, Mont L. Accuracy of standard bipolar amplitude voltage thresholds to identify late potential channels in ventricular tachycardia ablation. J Interv Card Electrophysiol. 2022 Feb 23.

2: Roca-Luque I, Van Breukelen A, Alarcon F, Garre P, Tolosana JM, Borras R, Sanchez P, Zaraket F, Doltra A, Ortiz-Perez JT, Prat-Gonzalez S, Perea RJ, Guasch E, Arbelo E, Berruezo A, Sitges M, Brugada J, Mont L. Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators. Europace. 2020 Apr 1;22(4):598-606.

3: Zaraket F, Bas D, Jimenez J, Casteigt B, Benito B, Martí-Almor J, Conejos J, Tizón-Marcos H, Mojón D, Vallès E. Cardiac Tomography and Cardiac Magnetic Resonance to Predict the Absence of Intracardiac Thrombus in Anticoagulated Patients Undergoing Atrial Fibrillation Ablation. J Clin Med. 2022 Apr 8;11(8):2101.

4: Sánchez-Somonte P, Quinto L, Garre P, Zaraket F, Alarcón F, Borràs R, Caixal G, Vázquez S, Prat S, Ortiz-Perez JT, Perea RJ, Guasch E, Tolosana JM, Berruezo A, Arbelo E, Sitges M, Mont L, Roca-Luque I. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention. Heart Rhythm. 2021 Aug;18(8):1336-1343.

5: Soto-Iglesias D, Penela D, Jáuregui B, Acosta J, Fernández-Armenta J, Linhart M, Zucchelli G, Syrovnev V, Zaraket F, Terés C, Perea RJ, Prat-González S, Doltra A, Ortiz-Pérez JT, Bosch X, Camara O, Berruezo A. Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation. JACC Clin Electrophysiol. 2020 Apr;6(4):436-447.

6: Roca-Luque I, Quinto L, Sanchez-Somonte P, Garre P, Alarcón F, Zaraket F, Vazquez S, Prat-Gonzalez S, Ortiz-Perez JT, Guasch E, Tolosana JM, Arbelo E, Berruezo A, Sitges M, Brugada J, Mont L. Late Potential Abolition in Ventricular Tachycardia Ablation. Am J Cardiol. 2022 Jul 1;174:53-60.

7: Quinto L, Sanchez P, Alarcón F, Garre P, Zaraket F, Prat-Gonzalez S, Ortiz- Perez JT, JesúsPerea R, Guasch E, Tolosana JM, San Antonio R, Arbelo E, Sitges M, Brugada J, Berruezo A, Mont L, Roca-Luque I. Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass. Europace. 2021 Sep 8;23(9):1437-1445

8: Jáuregui B, Soto-Iglesias D, Penela D, Acosta J, Fernández-Armenta J, Linhart M, Terés C, Syrovnev V, Zaraket F, Hervàs V, Prat-González S, Perea RJ, Morales- Ruiz M, Jiménez W, Lasalvia L, Bosch X, Ortiz-Pérez JT, Berruezo A. Follow-Up After Myocardial Infarction to Explore the Stability of Arrhythmogenic Substrate: The Footprint Study. JACC Clin Electrophysiol. 2020 Feb;6(2):207-218.

9: Gualandi F, Zaraket F, Malagù M, Parmeggiani G, Trabanelli C, Fini S, Dang X, Wei X, Fang M, Bertini M, Ferrari R, Ferlini A. Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome. Cardiology. 2017;137(4):256-260.

10: Biscaglia S, Tebaldi M, Tumscitz C, Pavasini R, Marchesini J, Gallo F, Spitaleri G, Zaraket F, Serenelli M, Cimaglia P, Bugani G, Campo G. Prospective Identification of Stent Fracture by Enhanced Stent Visualization System During Percutaneous Coronary Intervention. Circ J. 2016 Dec 22;81(1):82-89.

11: Balla C, Malagu' M, Fabbian F, Guarino M, Zaraket F, Brieda A, Smarrazzo V, Ferrari R, Bertini M. Prognosis after pacemaker implantation in extreme elderly. Eur J Intern Med. 2019 Jul;65:37-43.

12: Campo G, Pavasini R, Maietti E, Tonet E, Cimaglia P, Scillitani G, Bugani G, Serenelli M, Zaraket F, Balla C, Trevisan F, Biscaglia S, Sassone B, Galvani M, Ferrari R, Volpato S. The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clin Exp Res. 2017 Oct;29(5):895-903.

13: Pavasini R, Biscaglia S, d'Ascenzo F, Del Franco A, Contoli M, Zaraket F, Guerra F, Ferrari R, Campo G. Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis. COPD. 2016 Aug;13(4):509-14.

14: Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, Gallo F, Spitaleri G, Contoli M, Ferrari R, Campo G. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis. Chron Respir Dis. 2017 May;14(2):117-126.

15: Malagù M, Zaraket F, Gualandi F, Ferlini A, Brieda A, Vitali F, Del Franco A, Balla C, Fucili A, Ferrari R, Bertini M. Attualità e nuove prospettive in tema di cardiogenetica [Latest news and perspectives in cardiogenetics]. G Ital Cardiol (Rome). 2018 Feb;19(2):91-100.

Comunicaciones, participación en congresos y ponencias realizadas por el profesional

Certificaciones, premios y reconocimientos